ELOX insider transaction filings
Eloxx Pharmaceuticals, Inc. — 15 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-17. Screen ELOX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Domicilium Real Estate Fund III LP — 10% owner | Other (J): 238,422 · Other (J): 361,578 · Other (J): 238,422 (derivative) · Other (J): 361,578 (derivative) | EDGAR |
| 2026-06-10 | 4 | Webster Stephen W — Director | Grant/award (A): 13,587 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Walts Alan Edmund — Director | Grant/award (A): 8,590 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Aggarwal Sumit — President and CEO, Director | Grant/award (A): 328,833 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Kjellson Nina S — Director | Grant/award (A): 13,587 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Rubin Steven D — Director | Grant/award (A): 4,018 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Domicilium Real Estate Fund III LP — 10% owner | Other (J): 113,636 @ $0 · Other (J): 113,636 (derivative) | EDGAR |
| 2026-05-29 | 4 | Coastlands Capital LP — 10% owner | Other (J): 1,250,000 @ $0 · Other (J): 1,250,000 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Rubin Steven D — Director | Option exercise (M): 1,875 · Grant/award (A): 179,854 (derivative) @ $0 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Aggarwal Sumit — President and CEO, Director, 10% owner | Option exercise (M): 196,880 @ $0.00 · Grant/award (A): 1,000,000 @ $0 · Option exercise (M): 15,000 · Option exercise (M): 260,946 @ $0.15 · Grant/award (A): 42,790 (derivative) @ $0 · Disposition to issuer (D): 42,790 (derivative) · +14 more | EDGAR |
| 2026-05-08 | 4 | Walts Alan Edmund — Director | Option exercise (M): 1,875 · Grant/award (A): 395,680 (derivative) @ $0 · Option exercise (M): 1,875 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Aggarwal Sumit — Director | Option exercise (M): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Rubin Steven D — Director | Option exercise (M): 3,750 @ $0 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Androski Lindsay — Director | Option exercise (M): 3,750 @ $0 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Walts Alan Edmund — Director | Option exercise (M): 3,750 @ $0 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
Recent 8-K events — Eloxx Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-08-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ELOX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →